Related Experiment Videos
[Nodular dermohypodermatitis of the right arm]
F Vandenbos1, V Rahelinirina, P Dellamonica
1Service de maladies infectieuses et tropicales, Hôpital de l'Archet 1, CHU de Nice, 151, route St Antoine de Ginestière, BP 3079, 06202 Nice Cedex 3. vandenbos.f@chu-nice.fr
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
[Screening of children residing in the same household as patients with contagious tuberculosis].
Revue des maladies respiratoires·2026
[Comprehensiveness of LTBI treatment in individuals under 18 years old].
Revue des maladies respiratoires·2025
[Travel to South Africa by a patient on anti-TNF: Could tuberculosis have been prevented?]
Revue des maladies respiratoires·2025
[Ruxolitinib, disseminated tuberculosis and primary myelofibrosis: A case study].
Revue des maladies respiratoires·2025
[When tuberculosis makes you deaf].
Revue des maladies respiratoires·2025
[Diarrhea and HIV infection].
Medecine et maladies infectieuses·2024
Predictive analytics and risk stratification models in internal medicine: from risk scores to real-time machine learning.
Presse medicale (Paris, France : 1983)·2026
Artificial Intelligence in skin disease therapeutics: from drug discovery to personalized treatment pathways.
Presse medicale (Paris, France : 1983)·2026
AI in clinical diagnostics in dermatology: applications, validation, and real-world use cases.
Presse medicale (Paris, France : 1983)·2026
Artificial Intelligence in medical research and publishing: Progress, risks, and future perspectives.
Presse medicale (Paris, France : 1983)·2026
Ethical, legal, and regulatory challenges in AI-based healthcare tools.
Presse medicale (Paris, France : 1983)·2026
Beyond one-size-fits-all: Personalising health communication to drive real behaviour change.
Presse medicale (Paris, France : 1983)·2026
Upadacitinib for refractory generalized lichen sclerosus: a case report and brief literature review.
Frontiers in immunology·2026
Case Report: A case report of bullous pemphigoid triggered by sintilimab (PD-1 inhibitor).
Frontiers in immunology·2026